The most common actionable genetic alterations in the breast cancer cohort included: 8 PIK3CA (57%), 8 CDKN2A (57%), 6 FGFR (42%), 3 patients with DNA damage repair alterations (21%), and 4 PTEN (28%) (Fig. 4). Here, PTEN is linked to breast carcinoma.